Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Recombinant DNA01:09

Recombinant DNA

Overview
Immunoprecipitation01:20

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recombinant Human Fab Antibodies Differentially Neutralize Shiga Toxin in Renal Epithelial and Endothelial Cells.

Toxins·2026
Same author

Clarifying Frizzled 2 function in development through genetically validated mouse models.

Disease models & mechanisms·2026
Same author

Dual targeting of inhibitory EGFR epitopes with synthetic antibodies in therapeutic-resistant cancers.

Protein science : a publication of the Protein Society·2026
Same author

Structural Basis of Serine Protease Inhibition by Antibodies from Biased Fab Phage-Display Libraries.

bioRxiv : the preprint server for biology·2026
Same author

Paired Agent Imaging to Evaluate the Improvement of Affinity-Matured Nimotuzumab K4 and K5 Variants as EGFR-Detecting Optical Imaging Agents.

Molecular pharmaceutics·2026
Same author

Tetravalent antibodies are more potent and efficacious erythropoiesis-stimulating agents than erythropoietin in vivo.

Protein science : a publication of the Protein Society·2026

Related Experiment Video

Updated: May 21, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

Recombinant antibodies and in vitro selection technologies.

C Ronald Geyer1, John McCafferty, Stefan Dübel

  • 1University of Saskatchewan, Saskatoon, SK, Canada. ron.geyer@usask.ca

Methods in Molecular Biology (Clifton, N.J.)
|June 23, 2012
PubMed
Summary

Antibody phage display is a powerful in vitro method for creating antibodies, offering unique properties not achievable with traditional hybridoma techniques. This technology is ideal for high-throughput and therapeutic applications.

More Related Videos

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Related Experiment Videos

Last Updated: May 21, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
12:55

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Detailed knowledge of antibody structure and function has advanced antibody engineering.
  • Hybridoma technology has been the traditional method for antibody production.
  • Limitations exist in hybridoma methods for generating specific antibody properties.

Purpose of the Study:

  • To review antibody phage display technology.
  • To highlight antibodies with unique properties generated via phage display.
  • To compare phage display with traditional antibody creation methods.

Main Methods:

  • Antibody phage display as an in vitro technique.
  • Selection of antibodies under controlled conditions tailored to antigen demands.
  • Utilizing scalable molecular biology techniques for antibody generation.

Main Results:

  • Phage display enables creation of antibodies with unique properties unobtainable by hybridoma methods.
  • In vitro selection offers precise control over antibody generation.
  • The technology is suitable for high-throughput applications.

Conclusions:

  • Antibody phage display is a powerful alternative to hybridoma technology.
  • The method is well-suited for genome-scale biotechnology and therapeutic applications.
  • Phage display facilitates the generation of novel antibodies with desirable characteristics.